- Single‑chain RING finger ubiquitin ligases form an important subgroup of E3 enzymes within the ubiquitin–proteasome system. Unlike multi‑subunit Cullin–RING ligases, these enzymes consist of a single polypeptide that contains both the catalytic RING domain and the substrate‑binding regions required for ubiquitination. Their structural simplicity allows them to function autonomously, enabling rapid and direct regulation of protein stability and signalling pathways. The defining feature of these ligases is the RING domain, a zinc‑binding module composed of conserved cysteine and histidine residues arranged in a cross‑brace pattern. This structure coordinates two zinc ions and stabilises the domain, allowing it to bind ubiquitin‑charged E2 enzymes and facilitate direct ubiquitin transfer to substrates without forming a covalent intermediate.
- Several major families of single‑chain RING ligases play central roles in cellular regulation. MDM2 is one of the most extensively studied examples; it ubiquitinates the tumour suppressor p53 and thereby controls cell cycle progression, DNA damage responses, and apoptosis. Another key ligase is c‑Cbl, which targets receptor tyrosine kinases such as EGFR and regulates signal attenuation, immune responses, and receptor endocytosis. The BRCA1/BARD1 complex also belongs to this category, although it functions as a heterodimer of two RING‑containing proteins. BRCA1 provides the catalytic activity, while BARD1 stabilises the RING domain and enhances E3 function, together orchestrating homologous recombination and genome maintenance.
- The TRIM family represents one of the largest groups of single‑chain RING ligases. These proteins contain a RING domain, one or two B‑box domains, and a coiled‑coil region, enabling them to regulate innate immunity, antiviral defence, and protein quality control. TRIM21 and TRIM25 are well‑known members involved in interferon signalling and antibody‑mediated intracellular immunity. Another important group is the MARCH family, comprising membrane‑associated RING‑CH ligases that ubiquitinate membrane proteins, including immune receptors and transporters. These ligases play essential roles in antigen presentation, endosomal trafficking, and immune modulation.
- The TRAF family also contains RING‑domain proteins that function as E3 ligases in inflammatory and innate immune signalling. TRAF2 and TRAF6 are central regulators of NF‑κB activation and cytokine responses. Similarly, the inhibitor of apoptosis (IAP) family, including XIAP, cIAP1, and cIAP2, uses RING‑mediated ubiquitination to control apoptosis, cell survival, and immune signalling pathways. The RNF family encompasses numerous single‑chain RING ligases such as RNF4, RNF8, and RNF168, which are critical for DNA damage signalling, chromatin modification, and maintenance of genome stability.
- Mechanistically, single‑chain RING ligases operate through non‑covalent catalysis. The RING domain binds the ubiquitin‑charged E2 enzyme and positions it correctly relative to the substrate, enabling direct transfer of ubiquitin to lysine residues or the N‑terminus of the target protein. Substrate specificity is determined by additional domains within the same polypeptide, allowing each ligase to recognise distinct protein targets. These enzymes often assemble specific ubiquitin chain types, such as K48 or K63 linkages, which determine whether the substrate is destined for proteasomal degradation, altered trafficking, or modulation of signalling pathways.
- Biologically, single‑chain RING ligases regulate essential processes including cell cycle control, DNA repair, immune signalling, apoptosis, and receptor trafficking. Their dysregulation contributes to cancer, autoimmune disorders, neurodegeneration, and viral pathogenesis. Because of their central roles in cellular homeostasis, many of these ligases have become attractive therapeutic targets. MDM2 inhibitors are being developed for cancer therapy, while modulators of IAP proteins are under investigation for treating inflammatory diseases and malignancies.
- In summary, single‑chain RING finger ubiquitin ligases are versatile and autonomous regulators of protein ubiquitination. Their compact architecture, combined with diverse substrate‑binding capabilities, enables them to control key pathways in cell biology. Continued research into their mechanisms and functions is providing valuable insights into disease development and offering new opportunities for targeted therapeutic intervention.
